Technical factors associated with the benefit of prophylactic pancreatic stent placement during high-risk ERCP: a secondary analysis of the SVI trial dataset.
B Joseph ElmunzerJingwen ZhangGregory M CoteSteven A EdmundowiczSachin WaniRaj J ShahJi Young BangShyam VaradarajuluVikesh K SinghMouen KhashabRichard S KwonJames M ScheimanField F WillinghamSteven A KeilinGeorgios I PapachristouAmitabh ChakAdam SlivkaDaniel MulladyVladimir KushnirJames BuxbaumRajesh KeswaniTimothy B GardnerNauzer ForbesAmit RastogiAndrew S RossJoanna LawPatrick YachimskiYen-I ChenAlan BarkunZachary L SmithJose SerranoBret PetersenAndrew Y WangJohn R SaltzmanRebecca L SpitzerCollins OrdiahCathie SpinoLydia D FosterValerie Durkalski-Mauldinnull nullPublished in: The American journal of gastroenterology (2024)
The 5 modifiable technical factors studied in this secondary analysis of large-scale randomized trial data did not appear to have a strong impact on the benefit of prophylactic pancreatic stent placement in preventing PEP after high-risk ERCP. Within the limitations of post hoc subgroup analysis, these findings may have important implications in procedural decision-making and suggest that the benefit of PSP is robust to variations in technical approach.